Clinical Trials Directory

Trials / Completed

CompletedNCT01855191

SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

Standardized Data Collection (SDC) for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation (SDC Lung).

Status
Completed
Phase
Study type
Observational
Enrollment
864 (actual)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

Detailed description

All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling. Follow up at five time points: * 2 weeks after RT * 3 months after RT * 6 months after RT * 12 months after RT * 24 months after RT At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2019-02-01
Completion
2019-02-01
First posted
2013-05-16
Last updated
2019-03-26

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01855191. Inclusion in this directory is not an endorsement.